<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare two subcutaneous insulin strategies for glycemic management of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in non-<z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> hospitalized patients with <z:mp ids='MP_0002055'>diabetes</z:mp> during enteral nutrition therapy (ENT) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Fifty inpatients were prospectively randomized to receive sliding-scale regular insulin (SSRI) alone (n = 25) or in combination with insulin glargine (n = 25) </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> insulin was added for persistent <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in the SSRI group (<z:chebi fb="105" ids="17234">glucose</z:chebi> &gt;10 mmol/l) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Glycemic control was similar in the SSRI and glargine groups (mean +/- SD study <z:chebi fb="105" ids="17234">glucose</z:chebi> 8.9 +/- 1.6 vs. 9.2 +/- 1.6 mmol/l, respectively; P = 0.71) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> insulin was added in 48% of the SSRI group subjects </plain></SENT>
<SENT sid="5" pm="."><plain>There were no group differences in frequency of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (1.3 +/- 4.1 vs. 1.1 +/- 1.8%; P = 0.35), total adverse events, or length of stay </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Both insulin strategies (SSRI with the addition of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> for persistent <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and glargine) demonstrated similar efficacy and safety in non-<z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> hospitalized patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> during ENT </plain></SENT>
</text></document>